Liver Cancer Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Liver Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Nov 30, 2017

---

• A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection.  
  Zhang David Y et al. Gut 2016 Oct 65(10) 1754-64
• Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites.  
  Digennaro M et al. Hereditary cancer in clinical practice 2017 157
• Diagnosing Hepatorenal Tyrosinaemia in Europe: Newborn Mass Screening Versus Selective Screening.  
  Das Anibh M et al. Advances in experimental medicine and biology 2017 959125-132
• Remaining Challenges in the Treatment of Tyrosinemia from the Clinician's Viewpoint.  
  Mitchell Grant A et al. Advances in experimental medicine and biology 2017 959205-213
• Primary liver cancer genome sequencing: translational implications and challenges. 
  Ziogas Demosthenes E et al. Expert review of gastroenterology & hepatology 2017 Jul
• Viral Hepatitis and Liver Cancer 
• ALDH2 polymorphism and alcohol-related cancers in Asians: a public health perspective.  
  Chang Jeffrey S et al. Journal of biomedical science 2017 Mar 24(1) 19
• Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.  
  Durno Carol et al. Gastroenterology 2017 Mar
• Hepatocellular Carcinoma Risk in Alaska Native Children and Young Adults with Hepatitis B Virus: Retrospective Cohort Analysis.  
  Gounder Prabhu P et al. The Journal of pediatrics 2016 Aug
• Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.  
  Jourdain Gonzague et al. BMC infectious diseases 2016 16393